Co-Diagnostics, Inc. (FRA:C97)
Germany · Delayed Price · Currency is EUR 0.2140
+0.0120 (5.94%)
At close: Dec 19, 2025
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of €13.71 million as of December 22, 2025. Its market cap has decreased by -48.37% in one year.
Market Cap
13.71M
Enterprise Value
5.20M
Revenue
432.88K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.21
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from 60.69M to 13.71M, a decrease of -77.40%. That is a compound annual growth rate of -16.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 13.71M | -40.71% |
| Dec 31, 2024 | 23.13M | -37.14% |
| Dec 29, 2023 | 36.80M | -49.53% |
| Dec 30, 2022 | 72.90M | -68.16% |
| Dec 31, 2021 | 228.97M | 6.54% |
| Dec 31, 2020 | 214.92M | 1,453.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |